Tunable Polyglycerol-Based Redox-Responsive Nanogels for Efficient Cytochrome C Delivery.
iEDDA
nanogels
protein delivery
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
17 Aug 2021
17 Aug 2021
Historique:
received:
19
07
2021
revised:
10
08
2021
accepted:
12
08
2021
entrez:
28
8
2021
pubmed:
29
8
2021
medline:
29
8
2021
Statut:
epublish
Résumé
The sensitivity of therapeutic proteins is a challenge for their use in biomedical applications, as they are prone to degradation and opsonization, thus limiting their potential. This demands for the development of drug delivery systems shielding proteins and releasing them at the site of action. Here, we describe the synthesis of novel polyglycerol-based redox-responsive nanogels and report on their potential as nanocarrier systems for the delivery of cytochrome C (CC). This system is based on an encapsulation protocol of the therapeutic protein into the polymer network. NGs were formed via inverse nanoprecipitation using inverse electron-demand Diels-Alder cyclizations (iEDDA) between methyl tetrazines and norbornenes. Coprecipitation of CC led to high encapsulation efficiencies. Applying physiological reductive conditions of l-glutathione (GSH) led to degradation of the nanogel network, releasing 80% of the loaded CC within 48 h while maintaining protein functionality. Cytotoxicity measurements revealed high potency of CC-loaded NGs for various cancer cell lines with low IC
Identifiants
pubmed: 34452237
pii: pharmaceutics13081276
doi: 10.3390/pharmaceutics13081276
pmc: PMC8397965
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : BioSupraMol
Organisme : Freie Universität Berlin
ID : Dahlem Research School
Références
Angew Chem Int Ed Engl. 2009;48(38):6974-98
pubmed: 19714693
Langmuir. 2019 May 14;35(19):6231-6255
pubmed: 30998365
Front Bioeng Biotechnol. 2021 Feb 17;9:630943
pubmed: 33681168
Adv Drug Deliv Rev. 2012 Jun 15;64(9):836-51
pubmed: 22342438
Clin Exp Allergy. 2021 Jun;51(6):861-863
pubmed: 33825239
J Pharm Sci. 2016 Feb;105(2):460-475
pubmed: 26869412
J Control Release. 2013 Aug 10;169(3):289-95
pubmed: 23262202
Adv Drug Deliv Rev. 2003 Sep 26;55(10):1261-77
pubmed: 14499706
Int J Pharm. 1999 Aug 20;185(2):129-88
pubmed: 10460913
Angew Chem Int Ed Engl. 2006 Feb 13;45(8):1198-215
pubmed: 16444775
Macromol Biosci. 2017 Jan;17(1):
pubmed: 27430195
Macromol Rapid Commun. 2020 Jan;41(1):e1900510
pubmed: 31750985
Biomater Sci. 2017 Oct 24;5(11):2328-2336
pubmed: 29034396
Angew Chem Int Ed Engl. 2017 Jun 12;56(25):7088-7092
pubmed: 28455941
Biomater Sci. 2017 Oct 24;5(11):2295-2309
pubmed: 29019482
Acta Pharm Sin B. 2019 Jan;9(1):4-18
pubmed: 30766774
Expert Opin Biol Ther. 2016 Jul;16(7):903-15
pubmed: 26967759
J Control Release. 2016 Oct 28;240:109-126
pubmed: 26571000
ACS Appl Mater Interfaces. 2016 Aug 24;8(33):21155-62
pubmed: 27509045
Biomater Sci. 2015 Nov;3(11):1487-96
pubmed: 26288853
Theranostics. 2020 Jan 1;10(1):91-108
pubmed: 31903108
Biochemistry. 2020 Sep 8;59(35):3193-3200
pubmed: 32786406
Mol Genet Metab. 2021 Jul;133(3):250-256
pubmed: 34074593
J Control Release. 2011 May 30;152(1):2-12
pubmed: 21295087
BioDrugs. 2015 Aug;29(4):215-39
pubmed: 26177629
Angew Chem Int Ed Engl. 2009;48(30):5418-29
pubmed: 19562807
Angew Chem Int Ed Engl. 2010 Aug 23;49(36):6288-308
pubmed: 20648499
J Clin Pharmacol. 2021 Jun;61(6):832-835
pubmed: 33543766
Pharm Res. 2010 Apr;27(4):544-75
pubmed: 20143256
Haemophilia. 2020 Jan;26(1):156-163
pubmed: 31809565
Materials (Basel). 2021 Mar 18;14(6):
pubmed: 33803897